Control Bionics Ltd. · ASX:CBL
Control Bionics — Shareholder Meeting (October 2024)
22 slides from Control Bionics's shareholder meeting presentation, Oct 10, 2024
Slide 1: Annual General Meeting 10 October 2024
For personal use only Next-generation assistive technology and data measurement ANNUAL G EN ERAL MEET IN G 10 OC TOBE R 20 24 C O N TR O LB I ON I C S .C O M | AS X : C B L
Slide 2: Introduction
For personal use only Introduction Roger Hawke Chairman
Slide 3: Acknowledgment of Country
For personal use only Acknowledgment of Country I begin today by acknowledging the Gadigal people of the Eora Nation, Traditional Custodians of the land on which we meet today, and pay my respects to their Elders past, present and emerging. I extend that respect to Aboriginal and Torres Strait Islan
Slide 4: Disclaimer
For personal use only Disclaimer This presentation is intended to provide a general outline only and is not intended to be a definitive statement on the subject matter covered in it. The information in this presentation, whether written or verbal, has been prepared without taking into account the co
Slide 5: Experienced leadership
For personal use only PEOPL E Experienced leadership B O ARD • Over 20 years experience in accoun tin g, au dit ing and fin an ce roles in the United States and Aust ralia • Previously h eld senior finance positions with multi- national ASX-listed and technology start-up entities Shannon Boothroyd •
Slide 6: Voting Summary Report
4) AUTOMIC Q 1300 288 664 (within australia) O) Leste ps g Pru Street, Q +612 9698 5414 (International) ABN: 27 152 260 814 @ hello@automic.com.au © GPO Box 5193, (Q www.automic.com.au ‘Sudney NSW 2000 5 Voting Summary Report Control Bionics Limited Security Class(es): D) src cent necting cata Shoes
Slide 7: Voting Summary Report (continued)
a4) AUTOMIC 9 1300 288 664 within australia) | @ Level 5,126 Philip Steet '@ Report generated on 08-Oct-2024 at 12:37 PM Q +612 9698 5414 (international) ‘Sudney NSW 2000 (ABN: 27 152 260 814 @ hellozautomic.com.au = co Box S103, ( www.automic.com.au ‘Sydney NSW 2000 > — a = ee a)... pL ae 43,710133
Slide 8: CEO Presentation
For personal use only CEO Presentation Jeremy Steele
Slide 9: On the cusp of rapid global growth
For personal use only I NT R OD UC TI ON On the cusp of rapid global growth A proven medical device company with sizeable global sales of core products that we design and manufacture 20 years of Regulatory Core business Blue sky and Many levers for Near cash flow expertise with our clearance and con
Slide 10: Our strategic pillars for FY24
For personal use only F Y 24 R E VI EW Our strategic pillars for FY24 • Drive growth in the US to reach monthly breakeven • Enhance our software to support international growth, new products and new market segments beyond • Accelerate growth in Australia disability • Deliver first commercial sales o
Slide 11: Achieved many successful outcomes for our strategic initiatives
For personal use only F Y 24 R E VI EW Achieved many successful outcomes for our strategic initiatives • TGA aproval of DROVE as a Class I Medical Device • New US insurance code approved for NeuroNode, enabling a new US wholesale strategy • Successful development of NeuroStrip and initial customer t
Slide 12: Our focus for FY25 builds on the current strong momentum
For personal use only L OOK I NG F O R WA R D TO F Y 2 5 Our focus for FY25 builds on the current strong momentum • Reaching near-term EBITDA positive operations in all • New partnerships for standalone NeuroNode strategy key geographic markets for our primary AAC business in Japan and Europe • Achi
Slide 13: Financials: Record sales pipeline, building FY25 momentum
For personal use only F I NA N C IA LS REVENU E ( A$ m) EB IT DA ($A m ) Record sales pipeline, building FY25 momentum • FY24 revenue hit by ~$1M in NDIS delays. It’s improving with record processing in Aug-24 and Sept- 24 from our largest-ever backlog. • Record Q4 results in the USA following impro
Slide 14: Solutions
For personal use only Solutions Assistive Communication Assistive Mobility Data Measurement
Slide 15: Product overview: core products and those newly launched
For personal use only PROD UC T OVERVI EW Core products and those newly launched Currently assisting those disabled and leaping to new untapped markets CUSTOMERS CURRENT CORE PRODUCTS NEW PRODUCTS Disabled and diseased Speech-gen erat ing solut ion s with flexible access methods (tou ch, eye, EMG) t
Slide 16: Our core IP remains innovative and without major competition
For personal use only A S S IS T IV E CO MMUN I CA T ION Our core IP remains innovative and without major competition even today Our fastest near-term path to growth Those with degenerative neurological conditions, spinal cord injuries, cerebral palsy, and other conditions with movement restrictions
Slide 17: NeuroNode – How It Works
For personal use only NeuroNode – How It Works https://vimeo.com/controlbionics/neuronode
Slide 18: The world's first autonomous wheelchair
For personal use only A S S IS T IV E MOB IL IT Y The world’s first autonomous wheelchair Partnering with Deakin University, we made the world’s first upgrade for powered wheelchairs, so the user’s intentions can control them. DROVE is a patent pending module that retrofits powered wheelchairs. Its
Slide 19: Introducing DROVE
For personal use only Introducing DROVE https://vimeo.com/controlbionics/drove
Slide 20: The new NeuroStrip is a game-changer
For personal use only B E Y O N D A S S I ST IV E T E CH N O L O G Y The new NeuroStrip is a game-changer We are on a path to revolutionise new markets such as Market strategy: health diagnostics, sports science, critical care and more Enter those with the fastest, lowest- with the new miniaturisati
Slide 21: Introducing NeuroStrip
For personal use only Introducing NeuroStrip https://vimeo.com/controlbionics/neurostrip
Slide 22: Thank you
THANK YOU For personal use only JEREMY STEELE jsteele@controlbionics.com +65 9011 3975 (Singapore) +61 (0)433 229 470 (Australia) www.controlbionics.com